Status:
COMPLETED
Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis
Lead Sponsor:
Novartis
Conditions:
Osteoarthritis
Eligibility:
All Genders
35+ years
Phase:
PHASE3
Brief Summary
This study will test the efficacy and safety of topical diclofenac sodium gel in the treatment of knee osteoarthritis.
Eligibility Criteria
Inclusion
- Key Inclusion criteria
- Osteoarthritis of the knee Key Exclusion criteria
- Other rheumatic disease, such as rheumatoid arthritis
- Active gastrointestinal ulcer during the last year
- Known allergy to analgesic drugs
Exclusion
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00171626
Start Date
August 1 2004
End Date
June 1 2005
Last Update
April 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis Consumer Health Inc
Parsippany, New Jersey, United States